Study title: Hepatitis A vaccine versus immune globulin for postexposure prophylaxis; Hepatitis A vaccine versus immune globulin for postexposure prophylaxisUniversity of Michigan sponsored study performed in Kazakhstan Publication Citation: Hepatitis A Vaccine versus Immune Globulin for Postexposure Prophylaxis. Victor, J.C., et al., N. Engl. J. Med. 357 (17): 1685-1694, 2007
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Inactivated hepatitis A virus | |||||
ATC code: J07BC02 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |